Abbreviations
|
Full Names
|
ATRA |
all-trans retinoic acid |
BM |
bone marrow |
CAFs |
cancer-associated fibroblasts |
CSCs |
cancer stem cells |
ECM |
extracellular matrix; ECs: endothelial cells |
EMT |
epithelial mesenchymal transition |
FAP-α |
fibroblast activation protein-α |
FGF-2 |
fibroblast growth factor |
FGFs |
fibroblast growth factor |
FSP-1 |
fibroblast-specific protein-1 |
HGF |
hepatocyte growth factor |
HIF |
hypoxia-inducible factor |
IGF1 |
insulin-like growth factor 1 |
LOX |
lysyl oxidase |
MDR |
multidrug resistance |
MMPs |
matrix metalloproteases |
MSCs |
mesenchymal stem cells |
MT1-MMP |
membrane type 1-MMP |
NF-κB |
nuclear factor kappa B |
NG2 |
nerve/glial antigen-2 |
PD-L1 |
programmed death-ligand 1 |
PDGF |
platelet-derived growth factor |
PDGFR-β |
platelet-derived growth factor receptor-β |
SDF-1 |
Stromal cell-derived factor-1 |
TAAs |
tumor-associated adipocytes |
TAMs |
tumor-associated macrophages |
TECs |
tumor endothelial cells |
TEX |
tumor-derived exosomes |
TGFβs |
transforming growth factor βs |
TME |
tumor microenvironment |
TNF |
tumor necrosis factor |
TRAIL |
TNF-related apoptosis-inducing ligand |
VEGF |
vascular endothelial growth factor |
VEGFR-2 |
VEGF receptor 2 |
iPSCs |
induced pluripotent stem cells |
α-SMA |
alpha-smooth muscle actin. |